@ARTICLE{
author={Pillai Rathi N,Fennell Dean A,Kovcin Vladimir N,Ciuleanu Tudor E,Ramlau Rodryg,Kowalski Dariusz,Schenker Michael,Yalcin Ilker,Teofilovici Florentina,Vukovic Vojo M,Ramalingam Suresh S},
year={2020},
title={Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2)},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={38},
number={6},
pages={613-+},
document_type={Article},
} 

@ARTICLE{
author={Thongprasert Sumitra,Geater Sarayut L,Clement Dana,Abdelaziz Amr,Reyes-Igama Jasmin,Jovanovic Dragana D,Alexandru Aurelia,Schenker Michael,Sriuranpong Virote,Serwatowski Piotr,Suresh Sheethal,Cseh Agnieszka,Gaafar Rabab},
year={2019},
title={Afatinib in locally advanced/metastatic NSCLC harboring common <i>EGFR</i> mutations, after chemotherapy: a Phase IV study},
journal={LUNG CANCER MANAGEMENT},
volume={8},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Thongprasert Sumitra,Geater SL,Clement D,Abdelaziz A,Reyes-Igama J,Jovanovic D,Alexandru A,Schenker Michael,Sriuranpong Virote,Serwatowski P,Suresh S,Cseh Agnieszka,Gaafar Rabab},
year={2018},
title={Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC},
journal={ANNALS OF ONCOLOGY},
volume={29},
number={},
pages={146-146},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Pillai Rathi N,Fennell Dean,Kovcin Vladimir N,Ciuleanu Tudor E,Ramlau Rodryg,Kowalski Dariusz,Schenker Michael,Perin Branislav M,Yalcin Ilker,Teofilovici Florentina,Vukovic Vojo M,Ramalingam Suresh S},
year={2017},
title={Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={12},
number={1},
pages={S7-S8},
document_type={Meeting Abstract},
}